Literature DB >> 9119973

Differential regulation of cytokine-induced major histocompatibility complex class II expression and nitric oxide release in rat microglia and astrocytes by effectors of tyrosine kinase, protein kinase C, and cAMP.

R P Hellendall1, J P Ting.   

Abstract

Two glial cell populations of the CNS, astrocytes and microglia, were examined for expression of two immunologically important molecules, MHC class II and nitric oxide (NO), following treatment with cytokines. IFN-gamma induced both molecules in microglia at substantially higher levels than astrocytes. The addition of TNF-alpha to IFN-gamma elevated class II expression and NO in both cells. Genistein, an inhibitor of tyrosine kinases, and calphostin, an inhibitor of protein kinase C, diminished cytokine induction of class II MHC and NO in both glial populations. Forskolin was most effective in inhibiting class II MHC expression, but had little inhibitory effect on NO production. These results indicate microglia are more effective than astrocytes in producing cell-associated and secreted immune mediators in response to IFN-gamma and or TNF-alpha and multiple parallel, but distinct, signaling events are required for cytokine induced class II MHC or NO production.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119973     DOI: 10.1016/s0165-5728(96)00202-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

Review 1.  Immune players in the CNS: the astrocyte.

Authors:  Cathy J Jensen; Ann Massie; Jacques De Keyser
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-04       Impact factor: 4.147

2.  Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures.

Authors:  N R Bhat; P Zhang; J C Lee; E L Hogan
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

3.  Expression of CD54 (intercellular adhesion molecule-1) and the beta 1 integrin CD29 is modulated by a cyclic AMP dependent pathway in activated primary rat microglial cell cultures.

Authors:  S H Zuckerman; J Gustin; G F Evans
Journal:  Inflammation       Date:  1998-02       Impact factor: 4.092

4.  Obovatol attenuates microglia-mediated neuroinflammation by modulating redox regulation.

Authors:  Jiyeon Ock; Hyung S Han; Su H Hong; So Y Lee; Young-Min Han; Byoung-Mog Kwon; Kyoungho Suk
Journal:  Br J Pharmacol       Date:  2010-04       Impact factor: 8.739

5.  c-Jun and c-Fos regulate the complement factor H promoter in murine astrocytes.

Authors:  Laura A Fraczek; Carol B Martin; Brian K Martin
Journal:  Mol Immunol       Date:  2011-09-14       Impact factor: 4.407

6.  Interferon-gamma receptor-mediated but not tumor necrosis factor receptor type 1- or type 2-mediated signaling is crucial for the activation of cerebral blood vessel endothelial cells and microglia in murine Toxoplasma encephalitis.

Authors:  M Deckert-Schlüter; H Bluethmann; N Kaefer; A Rang; D Schlüter
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

Review 7.  Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions.

Authors:  Luisa Minghetti; Sergio Visentin; Mario Patrizio; Laura Franchini; Maria Antonietta Ajmone-Cat; Giulio Levi
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

Review 8.  Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders.

Authors:  Qiang Liu; Mo-Xian Chen; Lin Sun; Chloe U Wallis; Jian-Song Zhou; Li-Juan Ao; Qi Li; Pak C Sham
Journal:  World J Stem Cells       Date:  2019-02-26       Impact factor: 5.326

9.  Inhibition of LPS-Induced Microglial Activation by the Ethyl Acetate Extract of Pueraria mirifica.

Authors:  Nattinee Jantaratnotai; Anusorn Thampithak; Pongsak Utaisincharoen; Darawan Pinthong; Pimtip Sanvarinda
Journal:  Int J Environ Res Public Health       Date:  2022-10-09       Impact factor: 4.614

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.